Heqet Therapeutics
PrivateLast Round
Series A
Mar 23, 2022
Total Funding Raised
$8.7M
Company Overview
Heqet Therapeutics operates in Healthcare & Life Sciences and is based in Torino. Its latest recorded funding round was a Series A round in March 2022.
Heqet Therapeutics is a biotechnology company that develops non-coding RNA-based therapies for cardiovascular diseases, with a particular emphasis on acute myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heqet Therapeutics Comparables
Compare Heqet Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prolifagen | 85% | |
| Jaan Biotherapeutics | 84% | |
| Summa Biotech BV | 84% |
For institutional investors. Book with your work email.
Heqet Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Heqet Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Deutsche Balaton | Series A |
| Claris Ventures | Series A |
| 2invest AG | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors grew 122% MoM, reaching 1.1K.
- Nov 18, 2024
Monthly visitors increased 45% MoM.
For institutional investors. Book with your work email.
Heqet Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Heqet Therapeutics's valuation, stock price, and market status.
Is Heqet Therapeutics a public or private company?
Heqet Therapeutics is a private company.
What is the current stock price of Heqet Therapeutics?
Heqet Therapeutics is a private company, so its shares have no public market price. Caplight tracks Heqet Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Heqet Therapeutics worth (valuation)?
Valuation information for Heqet Therapeutics is not publicly available.
Can I buy Heqet Therapeutics stock?
Heqet Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Heqet Therapeutics's last funding round?
Heqet Therapeutics's most recent funding round was Series A on March 23, 2022.
Who are the main investors in Heqet Therapeutics?
Key investors in Heqet Therapeutics include Claris Ventures, 2invest AG.
Will Heqet Therapeutics IPO soon?
No public IPO plans have been announced for Heqet Therapeutics.
How can I track Heqet Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Heqet Therapeutics's shares on secondary markets.